diclofenac epolamine

diclofenac epolamine (LICART) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

LICART is a marketed brand name for diclofenac epolamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

diclofenac epolamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.